IL330385A - תצמיד נוגדן-פוליפפטיד ושימוש רוקחי בו - Google Patents
תצמיד נוגדן-פוליפפטיד ושימוש רוקחי בוInfo
- Publication number
- IL330385A IL330385A IL330385A IL33038526A IL330385A IL 330385 A IL330385 A IL 330385A IL 330385 A IL330385 A IL 330385A IL 33038526 A IL33038526 A IL 33038526A IL 330385 A IL330385 A IL 330385A
- Authority
- IL
- Israel
- Prior art keywords
- antibody
- pharmaceutical use
- polypeptide conjugate
- conjugate
- polypeptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311853381 | 2023-12-29 | ||
| PCT/CN2024/143340 WO2025140617A1 (zh) | 2023-12-29 | 2024-12-27 | 抗体-多肽偶联物及其医药用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL330385A true IL330385A (he) | 2026-08-01 |
Family
ID=96216874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL330385A IL330385A (he) | 2023-12-29 | 2024-12-27 | תצמיד נוגדן-פוליפפטיד ושימוש רוקחי בו |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN122341393A (he) |
| AU (1) | AU2024413886A1 (he) |
| CO (1) | CO2026010363A2 (he) |
| IL (1) | IL330385A (he) |
| TW (1) | TW202535467A (he) |
| WO (1) | WO2025140617A1 (he) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220153853A1 (en) | 2018-12-21 | 2022-05-19 | Jiangsu Hengrui Medicine Co., Ltd. | Bispecific protein |
| CN114853908B (zh) * | 2019-05-16 | 2024-06-07 | 浙江道尔生物科技有限公司 | 一种治疗代谢疾病的融合蛋白 |
| US12054551B2 (en) | 2020-07-02 | 2024-08-06 | Sanofi | FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptides |
| JP2023542295A (ja) * | 2020-09-14 | 2023-10-06 | リジェネロン ファーマシューティカルズ，インク． | Ｇｌｐ１ペプチド模倣薬を含む抗体薬物複合体及びその使用 |
| CA3211180A1 (en) * | 2021-02-22 | 2022-08-25 | Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Disaccharide linker, disaccharide-small molecule drug conjugate and sugar chain fixed-point antibody-drug conjugate, and preparation method therefor and use thereof |
| EP4392137A1 (en) * | 2021-08-27 | 2024-07-03 | Versanis Bio, Inc. | Combination therapies |
| WO2023046071A1 (zh) | 2021-09-23 | 2023-03-30 | 江苏恒瑞医药股份有限公司 | 抗klb抗体及用途 |
| EP4410307A4 (en) * | 2021-09-30 | 2026-05-06 | Jiangsu Hengrui Pharmaceuticals Co Ltd | PYRROLO BENZODIAZEPINE DERIVATIVE AND CONJUGATE, PROCESS FOR THEIR PREPARATION AND USE |
-
2024
- 2024-12-27 IL IL330385A patent/IL330385A/he unknown
- 2024-12-27 CN CN202480073019.0A patent/CN122341393A/zh active Pending
- 2024-12-27 WO PCT/CN2024/143340 patent/WO2025140617A1/zh active Pending
- 2024-12-27 TW TW113151273A patent/TW202535467A/zh unknown
- 2024-12-27 AU AU2024413886A patent/AU2024413886A1/en active Pending
-
2026
- 2026-07-17 CO CONC2026/0010363A patent/CO2026010363A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024413886A1 (en) | 2026-07-09 |
| WO2025140617A1 (zh) | 2025-07-03 |
| TW202535467A (zh) | 2025-09-16 |
| CN122341393A (zh) | 2026-07-03 |
| CO2026010363A2 (es) | 2026-07-31 |